BD² Has Opened Applications for New Clinical Sites

The BD² Integrated Network is seeking new partners in the U.S., Canada, and the U.K. to research bipolar disorder.

Updated on Sept. 29, 2026 in Mental Health

Isometric editorial illustration featuring a glass vial and a network of metallic nodes, representing an international clinical research collaboration.
BD² has opened a new application phase for clinical institutions to join its international network dedicated to longitudinal bipolar disorder research. AI Illustration. Upload story photo >

Live Poll

Do you trust that large research initiatives will improve care for people with mental health conditions?

BD² has launched a new application phase for clinical institutions to join its research network. The organization aims to expand its data collection efforts and improve care for individuals living with bipolar disorder.

Why it matters

Expanding the clinical network will increase the scale of longitudinal data available to researchers. This effort seeks to better understand the progression of bipolar disorder and enhance clinical outcomes for patients worldwide.

Selected clinical sites will receive up to $2.35 million USD in funding over a 5-year period. This initiative builds on the network's existing dataset, which already includes contributions from 615 research participants.

The players

BD²

This organization operates the Integrated Network to advance the study and treatment of bipolar disorder.

The details

Interested public, private, non-profit, and for-profit organizations that provide clinical care for bipolar disorder are eligible to apply. Successful candidates will contribute to the ongoing Longitudinal Cohort Study and the Learning Health Network.

Timeline

  1. March 2026: The network released a dataset containing information from 615 participants.

  2. September 29, 2026: BD² announced its third call for applications for new clinical sites.

  3. January 15, 2027: The deadline for organizations to submit their proposals.

  4. May 2027: Applicants will receive notification regarding their selection status.

  5. June 2027: The anticipated start date for new clinical sites to join the network.

The Big Picture

The expansion of the BD² Integrated Network follows a pattern set by large-scale collaborative health research initiatives. These programs aim to bridge the gap between clinical practice and scientific discovery through centralized data collection.

This network expansion may lead to improved standardized care protocols for people with bipolar disorder. Patients at participating clinics gain access to advanced research-driven insights and clinical trials coordinated through the network.

The takeaway

This initiative represents a significant push to standardize data collection for a complex condition. Interested clinical organizations should prepare their documentation early to meet the mid-January deadline.

What happens next

Organizations must submit their proposals by January 15, 2027, with award notifications expected in May 2027 and operations beginning in June 2027.

Further reading

For more on the current state of clinical research, visit the Mental Health section.

More information

View the application requirements and process on the BD² RFA Opportunities page.

Live Poll

Do you trust that large research initiatives will improve care for people with mental health conditions?